Stents Market Tops $5 Billion, Led by Drug-Eluting Devices

Stents Market Tops $5 Billion, Led by Drug-Eluting Devices 
NEW YORK, NY -- (Marketwire) -- 11/30/12 --   A growing acceptance of
drug-eluting stents as a more effective treatment for coronary heart
disease, along with increasing awareness about coronary stents among
patients, is expected to boost procedural volumes. As a result of
these factors, the global market for coronary stents is estimated at
over $5 billion, according to healthcare market research publisher
Kalorama Information's latest report, The World Market for Stents
(Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India,
China and ROW). 
Coronary stents are medical devices developed in the 1980s and
introduced to market in the early 1990s as a treatment modality for
heart disease. Used in bypass graft surgery and balloon angioplasty,
stents prevent the risk of abrupt artery closure and re-narrowing
that occurred in many patients following percutaneous coronary
interventions. Stents are placed at the site of blockage in the
coronary artery, and are kept in it permanently, with the scope of
maintaining the artery open, increasing the blood flow to the heart
muscle, and preventing restenosis. Currently, there are two major
types of coronary stents available in the market: bare metal stents
(BMS) and drug-eluting stents (DES). 
"One of the reasons for growth in the market is that the efficacy of
drug-eluting stents has been established now, after years of doubt,"
said Bruce Carlson, Publisher of Kalorama Information. "Increasing
disease incidence and new product innovations should drive sales." 
Kalorama indicates that the coronary stents industry is a highly
competitive one in which innovation occurs rapidly and the technology
landscape evolves at a fast pace. The leading players in the coronary
stents market in 2011 were Abbott Laboratories, Boston Scientific,
and Medtronic. The exit of Cordis Corporation (Johnson & Johnson)
from the coronary stents market in 2011, coupled with a series of new
product launches in major markets, induced significant shifts in
market dynamics. 
Kalorama Information's new report, The World Market for Stents
(Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India,
China and ROW), has further information on this market, including
l sales, segmented sales for bare metal and drug-eluting
stents, trends and other business planning information.  
About Kalorama Information
 Kalorama Information, a division of, supplies the latest in independent medical market
research in diagnostics, biotech, pharmaceuticals, medical devices
and healthcare; as well as a full range of custom research services.
We routinely assist the media with healthcare topics. Follow us on
Twitter, LinkedIn and our blog.  
Please direct all media inquiries to: 
Bruce Carlson 
Press spacebar to pause and continue. Press esc to stop.